R Gregory Bociek

Author PubWeight™ 17.73^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.	J Clin Oncol	2008	2.15
2	Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.	J Clin Oncol	2007	1.76
3	Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.	Lancet Oncol	2011	1.75
4	Adult Burkitt lymphoma: advances in diagnosis and treatment.	Oncology (Williston Park)	2008	1.40
5	A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.	Blood	2007	1.29
6	Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.	J Clin Oncol	2009	1.12
7	Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.	J Clin Oncol	2007	1.02
8	Cell of origin fails to predict survival in patients with diffuse large B-cell lymphoma treated with autologous hematopoietic stem cell transplantation.	Hematol Oncol	2011	0.98
9	ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.	Clin Cancer Res	2007	0.97
10	Lymphoma 2006: classification and treatment.	Oncology (Williston Park)	2006	0.85
11	Lymphodepleting effects and safety of pentostatin for nonmyeloablative allogeneic stem-cell transplantation.	Transplantation	2003	0.85
12	Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphoma.	Clin Lymphoma Myeloma Leuk	2013	0.84
13	Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.	PLoS One	2013	0.83
14	High-dose therapy/autologous hematopoietic stem cell transplantation in relapsed or refractory marginal zone non-Hodgkin lymphoma.	Clin Lymphoma Myeloma Leuk	2011	0.80
15	Follicular lymphoma: expanding therapeutic options.	Oncology (Williston Park)	2005	0.79
16	Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?	Clin Lymphoma Myeloma Leuk	2013	0.76
17	Increasing complexity of high-grade B-cell lymphomas.	Cancer	2014	0.75